The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Infarction, Middle Cerebral Artery

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Infarction, Middle Cerebral Artery

  • A case of acute closed brain trauma is presented in which the patient developed a right middle cerebral artery infarction, while frequent measurements of the arteriojugular lactate difference (AVDL) remained normal, failing to disclose ischemia [1].
  • Our findings facilitate early prediction of malignant edema formation and may help to increase knowledge of the pathophysiology of the peri-infarct zone of large MCA infarction [2].
  • Malignant MCA (m-MCA) infarction was diagnosed when follow-up CT detected a more than two-thirds space-occupying MCA infarction with midline shift, compression of the basal cisterns, and neurological deterioration [3].
 

High impact information on Infarction, Middle Cerebral Artery

 

Anatomical context of Infarction, Middle Cerebral Artery

  • CONCLUSIONS: We assume that reduction of non-transmitter amino acid concentrations reflects an expansion of the extracellular space by vasogenic edema formation in peri-infarct tissue of patients with malignant MCA infarction [2].
 

Gene context of Infarction, Middle Cerebral Artery

References

  1. Failure of jugular lactate determinations to disclose cerebral ischemia in posttraumatic cerebral infarction: case report. Cruz, J., Zager, E.L., Schnee, C.L., Gennarelli, T.A., Hoffstad, O.J. The Journal of trauma. (1993) [Pubmed]
  2. Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Bosche, B., Dohmen, C., Graf, R., Neveling, M., Staub, F., Kracht, L., Sobesky, J., Lehnhardt, F.G., Heiss, W.D. Stroke (2003) [Pubmed]
  3. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Serena, J., Blanco, M., Castellanos, M., Silva, Y., Vivancos, J., Moro, M.A., Leira, R., Lizasoain, I., Castillo, J., Dávalos, A. Stroke (2005) [Pubmed]
  4. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Büttner, T., Weyers, S., Postert, T., Sprengelmeyer, R., Kuhn, W. Stroke (1997) [Pubmed]
  5. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Minematsu, K., Li, L., Fisher, M., Sotak, C.H., Davis, M.A., Fiandaca, M.S. Neurology (1992) [Pubmed]
  6. Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia. Prehn, J.H., Backhauss, C., Karkoutly, C., Nuglisch, J., Peruche, B., Rossberg, C., Krieglstein, J. Eur. J. Pharmacol. (1991) [Pubmed]
  7. Contralateral subdural effusion after aneurysm surgery and decompressive craniectomy: case report and review of the literature. Kilincer, C., Simsek, O., Hamamcioglu, M.K., Hicdonmez, T., Cobanoglu, S. Clinical neurology and neurosurgery. (2005) [Pubmed]
 
WikiGenes - Universities